[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@doepke_michel "$BSLN #Basilea awarded #BARDA contract for the development of novel oral phase 3-ready antibiotic ceftibuten-leaborbactam. Total non-dilutive funding of up to $159M"
X Link @doepke_michel 2025-09-25T05:28Z 5558 followers, 1045 engagements

"$GALD #Galderma Delivers Record First Half 2025 Net Sales of XXXXX Billion USD and XXXX% Year-on-Year Growth at Constant Currency Raises Full-Year Top-Line Guidance"
X Link @doepke_michel 2025-07-24T05:35Z 5561 followers, XXX engagements

"$ABVX rated new "Overweight" at Barclays. PT $142"
X Link @doepke_michel 2025-10-13T09:58Z 5561 followers, 19.1K engagements

"$ONMD Selects $PLTR to Advance Healthcare AI and Data Analytics"
X Link @doepke_michel 2025-10-06T11:02Z 5561 followers, XXX engagements

"$SMMT to Host ESMO Data Update & Third Quarter Earnings Call on October XX 2025. $PFE $BNTX $BMY"
X Link @doepke_michel 2025-10-15T11:00Z 5562 followers, XXX engagements

"$GMAB to acquire $MRUS Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model"
X Link @doepke_michel 2025-09-29T05:23Z 5561 followers, 6603 engagements

"$AKRO to be Acquired by Novo Nordisk for up to $XXX Billion. $NVO #MASH"
X Link @doepke_michel 2025-10-09T10:17Z 5559 followers, 1033 engagements

"$MRK Completes Acquisition of $VRNA ✅"
X Link @doepke_michel 2025-10-07T10:47Z 5555 followers, 2909 engagements

"$BMRN Reports Strong Second Quarter 2025 Results and Raises Full-year Guidance for Total Revenues Non-GAAP Operating Margin and Non-GAAP Diluted EPS"
X Link @doepke_michel 2025-08-04T20:09Z 5561 followers, XXX engagements

"OpenAI and $AVGO strategic collaboration to deploy XX gigawatts of OpenAI-designed AI accelerators"
X Link @doepke_michel 2025-10-13T13:02Z 5559 followers, 4985 engagements

"$NVO key catalysts (source: Morgan Stanley). $LLY $BIIB"
X Link @doepke_michel 2025-10-01T09:26Z 5558 followers, 6315 engagements

"$RCUS Anti-TIGIT Domvanalimab Plus Anti-PD-1 Zimberelimab and Chemotherapy Showed XXXX Months of Median Overall Survival as First-Line Treatment of Unresectable or Advanced Gastroesophageal Adenocarcinomas in the Phase X EDGE-Gastric Study. $GILD"
X Link @doepke_michel 2025-10-13T05:37Z 5559 followers, 1055 engagements

"$BBIO $NBIX JPMorgan Q3 preview"
X Link @doepke_michel 2025-10-15T10:21Z 5562 followers, X engagements

"$JAZZ Enters Exclusive Licensing Agreement with Saniona to Develop and Commercialize SAN2355. Saniona to receive US $42.5M upfront. $SANION.ST"
X Link @doepke_michel 2025-08-20T14:45Z 5556 followers, 1582 engagements

"2025 pharma M&A surges to $XX billion in major deals. $AKRO $VRNA $SWTX $BPMC $ETNB $ITCI $MTSR and more gone. $PTGX next"
X Link @doepke_michel 2025-10-11T13:48Z 5561 followers, 3472 engagements

"$PTGX drops Betaville says Asset Sales May Only Fetch $XX. Blackstone is rumored to be the buyout firm working with $JNJ on the takeover of a "large" of $PTGX according to the betaville report"
X Link @doepke_michel 2025-10-13T17:13Z 5561 followers, 7515 engagements

"$BMY Anti-MTBR-Tau-Targeting Antibody BMS-986446 Granted Fast Track Designation by U.S. FDA for the Treatment of Alzheimers Disease. $LLY $BIIB"
X Link @doepke_michel 2025-10-01T11:04Z 5559 followers, 1346 engagements

"Interesting to see that there was a "party 1" to acquire $MTSR. $PFE did. Maybe the "party 1" is now looking for other #obesity pipeline assets (and those that are close by) $VKTX $GPCR $SRRK $RYTM"
X Link @doepke_michel 2025-10-06T11:32Z 5559 followers, 3373 engagements

"$SRRK $CTLT $NVO"
X Link @doepke_michel 2025-09-23T11:02Z 5558 followers, 7353 engagements

"$ORSTED $ORSTED.CO plan for a rights issue with support from the Danish State as majority shareholder and gross proceeds of DKK XX billion. XX% of the market cap before the announcement. Heavy dilution"
X Link @doepke_michel 2025-08-11T07:07Z 5558 followers, 1458 engagements

"#BoehringerIngelheim - Pooled data presented at ERS: nerandomilast monotherapy linked to nominally significant reduction in risk of death in IPF and PPF. $UTHR"
X Link @doepke_michel 2025-09-29T06:09Z 5561 followers, 1003 engagements

"$REGN Showcases Advances Across Oncology Portfolio and Pipeline at ESMO Highlighting Novel and Patient-Focused Approach for Difficult-to-Treat Cancers"
X Link @doepke_michel 2025-10-15T11:02Z 5562 followers, XXX engagements

"$ONC Sonrotoclax Granted Breakthrough Therapy Designation by U.S. FDA"
X Link @doepke_michel 2025-10-13T10:01Z 5560 followers, XXX engagements

"$PTGX M&A candidate imo. Potential suitors: $JNJ and $BMY. Own shares"
X Link @doepke_michel 2025-10-10T12:44Z 5561 followers, 27.8K engagements

"$NVO $NOVOB #NovoNordisk - new #Semaglutide combination got positive CHMP opinion. $LLY"
X Link @doepke_michel 2025-09-19T12:02Z 5558 followers, 2840 engagements

"After $ETNB and $AKRO buyouts maybe $ALT will finally wake up. I have a small position"
X Link @doepke_michel 2025-10-09T11:12Z 5561 followers, 2201 engagements

"$LPTX Announces $58.88M Private Placement in Cash Commitments Led by Winklevoss Capital to Initiate a Digital Asset Treasury Strategy. = 3x market cap at yesterdays closing"
X Link @doepke_michel 2025-10-06T13:09Z 5556 followers, 9564 engagements

"$OCUL Receives FDA Agreement Under Special Protocol Assessment (SPA) for Registrational Trial of AXPAXLI in NPDR"
X Link @doepke_michel 2025-08-12T11:02Z 5558 followers, 8823 engagements

"Keep in mind: $MRK acquired $RXDX for $10.8B after a successful phase X with TL1A antibody (competitive landscape + deals below) Tulisokibart (now phase 3). So what is $ABVX worth after the Obefazimod phase X data in UC (Discl.: I own shares)"
X Link @doepke_michel 2025-10-06T13:00Z 5558 followers, 13K engagements

"#ESMO25 next week(end). $AZN vs. $GILD. Also looking for data/Updates from: $KURA $IDYA $CELC $IMTX $SMMT and more"
X Link @doepke_michel 2025-10-12T10:50Z 5561 followers, 5972 engagements

"Added $BRKR"
X Link @doepke_michel 2025-10-03T14:14Z 5561 followers, 3767 engagements

"$CYTK Barclays update from earlier this week. PT to $XX. $BMY"
X Link @doepke_michel 2025-10-10T11:28Z 5561 followers, 8124 engagements

"$BMRN Announces Positive Pivotal Phase X Data for PALYNZIQ (pegvaliase-pqpz) in Adolescents with Phenylketonuria at 15th International Congress of Inborn Errors of Metabolism"
X Link @doepke_michel 2025-09-06T15:27Z 5555 followers, 1804 engagements

"$PTGX (Ikatrekibart) - exciting to see how enthusiastically JNJ talks about the field of immunology - maybe $JNJ needs an oral option for IBD (UC and CD) too $ABVX"
X Link @doepke_michel 2025-10-14T17:19Z 5561 followers, 3250 engagements

"$JNJ Reports Q3 2025 Results; Raises 2025 Sales Outlook"
X Link @doepke_michel 2025-10-14T10:32Z 5561 followers, XXX engagements

"$IDIA #Idorsias TRYVIO First FDA-approved therapy to target the endothelin pathway for systemic hypertension"
X Link @doepke_michel 2025-08-28T05:03Z 5561 followers, XXX engagements

"$REGN Libtayo (cemiplimab-rwlc) Approved in the U.S. as First and Only Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma (CSCC) with a High Risk of Recurrence After Surgery and Radiation. $SRRK 👀"
X Link @doepke_michel 2025-10-08T18:50Z 5560 followers, 2360 engagements

"The current rumors surrounding $PTGX strongly remind me of the takeover of $BHVN by $PFE. Perhaps there will soon be a New PTGX I just hope that the company does not sell itself below value. The pipeline has enormous potential in the long term. $JNJ"
X Link @doepke_michel 2025-10-13T18:42Z 5561 followers, 4156 engagements

"$SNY AlphaMedixTM (212Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase X study demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors"
X Link @doepke_michel 2025-10-08T05:17Z 5558 followers, 2680 engagements

"#Chikungunya Outbreaks Cause Concern When Visiting France and Italy. $BAVA #BavarianNordic $VLA #Valneva"
X Link @doepke_michel 2025-09-17T09:55Z 5561 followers, 1502 engagements

"$ARVN $PFE to Present Data from the Vepdegestrant Clinical Development Program at the 2025 European Society for Medical Oncology (ESMO) Congress"
X Link @doepke_michel 2025-10-13T11:03Z 5561 followers, 1247 engagements

"BREAKING: ADCs are 🔥- German based #Tubulis Raises XXX Million Series C to Accelerate Clinical Development of Lead ADC Candidate TUB-040 and Expand Pipeline. Partner: $GILD and $BMY"
X Link @doepke_michel 2025-10-15T09:06Z 5562 followers, XXX engagements

"$ONC Medicines Announces IMDELLTRA Royalty Purchase Agreement for up to $950M. $RPRX $AMGN"
X Link @doepke_michel 2025-08-25T10:09Z 5561 followers, XXX engagements

"SystImmune to Receive Milestone Payment from $BMY Under Iza-Bren Collaboration. This milestone triggered a one-time payment of $250M"
X Link @doepke_michel 2025-10-13T09:02Z 5559 followers, XXX engagements

"$CAI Q2 results - Reported total revenue of $XXXXX million an increase of XXXX% - positive Adjusted EBITDA of $XXXX million"
X Link @doepke_michel 2025-08-12T20:09Z 5558 followers, 3626 engagements

"$PTGX early stage program but PN-881 could have gamechanger potential. It's incredible how strongly $UCB is growing with Bimzelx. A multi-billion dollar opportunity - and $JNJ may be aware of this potential. Maybe we get a PR tomorrow - $JNJ to report Q3 results on Tuesday. $NVS"
X Link @doepke_michel 2025-10-12T18:25Z 5561 followers, 3305 engagements

"DB-OTO Results in theNEJM Showcase Dramatic and Sustained Improvements in Hearing and Speech Perception in Children with Profound Genetic Hearing Loss. $REGN acquired $DBTX back in August 2023 for a total EV of up to approximately $213M including CVR"
X Link @doepke_michel 2025-10-12T15:05Z 5561 followers, 2367 engagements

"$TVRD Provides Update on Preliminary Data from Phase X REVERT Trial in Idiopathic Pulmonary Fibrosis. #FAIL $UTHR"
X Link @doepke_michel 2025-10-13T11:31Z 5561 followers, 1912 engagements

"$REGN Announces Positive Results from Phase X Trial in Generalized Myasthenia Gravis. $ARGX"
X Link @doepke_michel 2025-08-26T11:02Z 5561 followers, 2958 engagements

"nHCM landscape (source: Barclays). $CYTK $LXRX $EWTX $TNYA $LXEO"
X Link @doepke_michel 2025-10-10T11:25Z 5561 followers, 2078 engagements

"$IMRX Announces Pricing of $XXX Million Underwritten Public Offering of Class A Common Stock and Concurrent $XX Million Private Placement of Class A Common Stock to $SNY - $XXXX per share"
X Link @doepke_michel 2025-09-25T05:03Z 5559 followers, 1370 engagements

"$SBSW $SSW.JO 💪 (I own shares) #Platinum"
X Link @doepke_michel 2025-09-26T07:50Z 5558 followers, 1410 engagements

"@financebully @pnani456 Betaville has had so many rumors and uncooked alerts in the past that turned out to be nothing - take this with a grain of salt. The fact is: $JNJ earnings tomorrow. $PTGX"
X Link @doepke_michel 2025-10-13T17:41Z 5561 followers, 4827 engagements

"$CTMX I like this slide. ADCs are 🔥 M&A deals: Padcev - $SGEN - $PFE Elahere - $IMGN - $ABBV Trodelvy - $IMMU - $GILD Enhertu - Daiichi Sankyo - $AZN partnership value up to $7B. CX-2051 - $CTMX - (I own shares)"
X Link @doepke_michel 2025-09-26T12:25Z 5561 followers, 6981 engagements

"$BAYN #Bayer Elinzanetant recommended for approval in EU as treatment of moderate to severe vasomotor symptoms. #Astellas"
X Link @doepke_michel 2025-09-19T10:44Z 5558 followers, 1340 engagements

"$SNY $REGN Dupixent to treat chronic spontaneous urticaria advances in EU with positive CHMP opinion. $CLDX $BPMC"
X Link @doepke_michel 2025-09-22T05:01Z 5561 followers, 1691 engagements

"$IDYA Announces Positive Interim Phase X Data for Darovasertib in the Neoadjuvant Setting of Primary Uveal Melanoma. $IMCR"
X Link @doepke_michel 2025-09-08T11:21Z 5555 followers, 1312 engagements

"$NVS receives FDA approval for Rhapsido (remibrutinib) the only oral targeted BTKi treatment for chronic spontaneous urticaria (CSU). $BPMC $SNY $CLDX $JSPR"
X Link @doepke_michel 2025-10-01T05:52Z 5559 followers, 2383 engagements

"$IDIA JERAYGO (aprocitentan) approved in Switzerland for the treatment of resistant hypertension"
X Link @doepke_michel 2025-09-19T05:06Z 5561 followers, 1124 engagements

"Consortium Led by Nordic Capital and Permira Will Make All-Cash Recommended Purchase Offer for $BAVA $BAVA.CO - offer price: DKK 233"
X Link @doepke_michel 2025-07-28T06:12Z 5561 followers, 1247 engagements

"Baker Bros. 13F filings. Top 10: $ONC $INCY $ACAD $INSM $SMMT $MDGL $RYTM $RVMD $KYMR $ALKS"
X Link @doepke_michel 2025-08-15T12:12Z 5561 followers, 7478 engagements

"$LRMR Announces Positive Data from Ongoing Long-term Open Label Study and Updates to Nomlabofusp Program for Friedreichs Ataxia. $BIIB $RETA"
X Link @doepke_michel 2025-09-29T11:02Z 5558 followers, 1883 engagements

"$SNY SAR446268 earns US fast track designation for the treatment of non-congenital myotonic dystrophy type 1"
X Link @doepke_michel 2025-09-23T05:02Z 5554 followers, 2479 engagements

"$CGON Continues to Demonstrate Best-in-Disease Durability and Tolerability in BOND-003 Cohort C; Additional XX Patients in Complete Response at XX Months"
X Link @doepke_michel 2025-09-05T11:26Z 5559 followers, XXX engagements

"#NovoNordisk Foundation commits up to DKK XXX million to fund new platform to strengthen global defence against future pandemics. $NVO"
X Link @doepke_michel 2025-10-13T05:39Z 5558 followers, 1221 engagements

"@bio_clouseau Maybe the (potential) deal will be announced as part of the Q3 earnings tomorrow. $PTGX $JNJ"
X Link @doepke_michel 2025-10-13T11:47Z 5558 followers, XXX engagements

"Kailera Therapeutics Announces $XXX Million Series B Financing to Further Advance Pipeline of Next-Generation Therapies for the Treatment of Obesity. $NVO $LLY $VKTX $MTSR"
X Link @doepke_michel 2025-10-14T10:33Z 5561 followers, 5108 engagements

"$UCB BIMZELX (bimekizumab-bkzx) New Three-year Data in Hidradenitis Suppurativa at EADV Showed Sustained Symptom Relief Across Multiple Clinical Endpoints. $MLTX $SNY"
X Link @doepke_michel 2025-09-17T11:04Z 5561 followers, 1973 engagements

"$UTHR to Feature Clinical Data at the CHEST 2025 Annual Meeting"
X Link @doepke_michel 2025-10-13T11:01Z 5561 followers, XXX engagements

"$ZEAL upcoming events next XX months. Ended Q2 with 2.2B cash. Market cap: 3.3B. No extraordinary dividend planned like $GUBRA did. $RHHBY $LLY $NVO"
X Link @doepke_michel 2025-08-14T05:26Z 5554 followers, 1298 engagements

"Barclays yesterday: On $ABVX says differentiated mechanism has company uniquely positioned with its development of a novel oral molecule for UC and CD "two large chronic indications with high unmet need""
X Link @doepke_michel 2025-10-14T13:01Z 5561 followers, 4420 engagements

"$NVO $NOVOB #NovoNordisk oral semaglutide XX mg (Wegovy in a pill) delivered XXXX% weight loss in people with obesity in a newly published study. $LLY"
X Link @doepke_michel 2025-09-18T05:14Z 5558 followers, 1127 engagements

"$NBIX Q2 earnings after-hours today $BMY $ABBV $APLS tomorrow $REGN on Friday. $KRYS $TGTX $AXSM Q2 results on August X 2025 $MDGL $DAWN $BBIO Q2 results on August X 2025 $IOVA Q2 results on August X 2025"
X Link @doepke_michel 2025-07-30T12:49Z 5555 followers, 8285 engagements

"$PFE invested about X years ago in $AKRO. They sold the stake some weeks ago - it would be typical for Pfizer if $AKRO is bought out soon"
X Link @doepke_michel 2025-05-31T09:38Z 5558 followers, 5358 engagements

"$GUTS Announces Potent Preclinical Results from RJVA-002 a Dual GIP/GLP-1 Gene Therapy Candidate for Obesity"
X Link @doepke_michel 2025-10-07T11:05Z 5561 followers, 3198 engagements

"$NVAX Continues to Deliver on $SNY Partnership Completing Nuvaxovid EU Marketing Authorization Transfer and Triggering $XX Million Milestone Payment"
X Link @doepke_michel 2025-10-07T11:03Z 5559 followers, 1242 engagements

"$BCRX down XX% after acquisition news. The company is now trading at 2x the expected ORLADEYO revenue for 2025 (at the upper end)"
X Link @doepke_michel 2025-10-14T18:47Z 5561 followers, 1648 engagements

"$AKRO $NVO - yesterday I wrote: "In any case acquisitions could play a more important role in the strategy of the new CEO Doustdar than under his predecessor in order to expand the development pipeline with further promising product candidates." #MASH"
X Link @doepke_michel 2025-10-09T10:49Z 5559 followers, 1094 engagements

"$BRKR has had a tough couple of quarters. But there are signs of improvement - it seems that investment in research and science is picking up. Bruker is benefiting from this (see latest news) - on top of that there is some AI fantasy. #Metrology"
X Link @doepke_michel 2025-10-06T11:49Z 5561 followers, 1898 engagements

"I mentioned it already in April that $PTGX would be a perfect bolt-on acquisition target for $JNJ. M&A is heating up. 🔥 $AKRO $NVO #OrbitalTherapeutics $BMY"
X Link @doepke_michel 2025-10-10T16:13Z 5558 followers, 2608 engagements

"Exciting phase for $SRRK following the CRL and the discontinuation of the $LLY study with Zepbound for muscle preservation. Shares showing strength. What happens next"
X Link @doepke_michel 2025-09-30T12:05Z 5554 followers, 2351 engagements

"$BIOAB $BIOA.ST #BioArctic Leqembi Iqlik (lecanemab-irmb) maintenance treatment launched in the US. $BIIB #Eisai"
X Link @doepke_michel 2025-10-07T05:57Z 5560 followers, XXX engagements

"$EVT #Evotec and #Sandoz planning potential sale of Just Evotec Biologics Toulouse site (for a consideration of about $300M). They invested heavily in the site in 2024. 👇🤔"
X Link @doepke_michel 2025-07-30T08:52Z 5562 followers, 2502 engagements

"$INCY Announces New 24-Week Phase X Data from the STOP-HS Clinical Trial Program of Povorcitinib in Hidradenitis Suppurativa at EADV 2025. $SNY $MLTX"
X Link @doepke_michel 2025-09-17T05:10Z 5561 followers, 1811 engagements

"$BMY patent cliff is a huge problem for the company. Expensive acquisitions $KRTX $MYOK (Camzyos sales accelerating but $CYTK might have the better drug) $MRTX $RYZB and $CELG in the past. BMS needs commercial drug assets imo. $MDGL $BBIO $AXSM $NBIX $TLX"
X Link @doepke_michel 2025-10-12T13:41Z 5561 followers, 8139 engagements

"$PTGX $XXX per share are $7B valuation. I hope for more huge pipeline potential in the long term. (Own shares) $JNJ $ABVX"
X Link @doepke_michel 2025-10-11T19:53Z 5558 followers, 4456 engagements

"$NVO $NOVOB #NovoNordisk Ozempic reduces the risk of heart attack stroke and death by XX% compared to dulaglutide in the first head-to-head real-world study. $LLY"
X Link @doepke_michel 2025-09-18T08:52Z 5558 followers, XXX engagements

"And again good news for the biopharma sector: #Lonza Delivers Strong H1 2025 Performance and Upgrades 2025 Full-Year CDMO Sales and Margin Outlook"
X Link @doepke_michel 2025-07-23T05:20Z 5557 followers, 1693 engagements

"$CTMX next leg up soon (Own shares)"
X Link @doepke_michel 2025-10-14T16:53Z 5561 followers, 1438 engagements

"$PFE $SGEN TUKYSA Combination Significantly Improves Progression-Free Survival as First-Line Maintenance in HER2+ Metastatic Breast Cancer in HER2CLIMB-05 Trial"
X Link @doepke_michel 2025-10-14T10:50Z 5561 followers, XXX engagements

"$MRK $VRNA Transaction expected to be closed today"
X Link @doepke_michel 2025-10-07T08:48Z 5559 followers, 4249 engagements

"NAILED IT $JNJ in Talks to Buy $PTGX 💪😎🥳"
X Link @doepke_michel 2025-10-10T15:30Z 5559 followers, 8066 engagements

"#Boehringers Jascayd becomes first new IPF treatment in US for a decade. $UTHR"
X Link @doepke_michel 2025-10-08T12:05Z 5557 followers, XXX engagements

"$BMY Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of #Orbital Therapeutics for $1.5B in cash. $ABBV"
X Link @doepke_michel 2025-10-10T11:32Z 5559 followers, 1437 engagements

"$MDT initiates U.S. IDE clinical study evaluating Hugo robotic-assisted surgery system for gynecological procedures. $ISRG"
X Link @doepke_michel 2025-10-08T11:02Z 5558 followers, XXX engagements

"$LNTH and $GEHC Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY (Piflufolastat F 18) in Japan"
X Link @doepke_michel 2025-09-24T05:25Z 5561 followers, 1364 engagements

"$SNY Sanofis brivekimig achieved positive results in hidradenitis suppurativa in phase 2a study. $MLTX"
X Link @doepke_michel 2025-09-17T05:08Z 5561 followers, 22.9K engagements

"$BRKR Announces Orders for NIH- and NSF-Funded NMR Systems from New York Structural Biology Center University of Delaware and Northwestern University"
X Link @doepke_michel 2025-10-03T11:03Z 5559 followers, 2788 engagements

"PD1/VEGF deals: $PFE -- #3SBio $SMMT -- #Akeso $BNTX -- #Biotheus. I wouldn't be surprised if CS2009 from #CStone (PD-1/VEGF/CTLA-4) will gain interest from western biopharma companies too. They have already broad partnerships with $BPMC and $PFE"
X Link @doepke_michel 2025-05-20T09:05Z 5555 followers, 1049 engagements

"#Icotrokinra seems very important for $JNJ. 2026 considerations below. $PTGX"
X Link @doepke_michel 2025-10-14T10:47Z 5562 followers, 3054 engagements

"$UCB shares up X% in early European trading after disappointing $MLTX HS results. #Bimzelx sales nearly quadrupled in the first half of the year. The momentum is likely to continue"
X Link @doepke_michel 2025-09-29T06:17Z 5558 followers, 7605 engagements

"$OCUL takeover speculation betaville"
X Link @doepke_michel 2025-09-05T18:48Z 5558 followers, 4131 engagements